Improving survival from metastatic, recurrent, or persistent cervical cancer
Details
Publication Year 2024-01-06,Volume 403,Issue #10421,Page 2-4
Journal Title
Lancet
Publication Type
Commentary
Publisher
Elsevier
Keywords
Female; Humans; *Uterine Cervical Neoplasms/drug therapy; Bevacizumab/therapeutic use; Paclitaxel/therapeutic use; Neoplasm Recurrence, Local/drug therapy; Antineoplastic Combined Chemotherapy Protocols
Department(s)
Medical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-02-20 12:41:05
Last Modified: 2024-02-22 12:34:29

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙